Andreas Blaeser
Papers
2
Total Citations
38
H-Index
2
About
Andreas Blaeser is a pioneering figure at the intersection of bioprinting and microphysiological systems, driving the automation and scalability of organ-on-a-chip (OOC) technologies. His research focuses on developing high-throughput fabrication platforms that can produce complex, vascularized tissue models for pharmaceutical testing. Blaeser’s major contributions include the design of a high-scale 3D-bioprinting platform capable of automated OOC production, which integrates robotic handling and manipulation to overcome critical bottlenecks in commercialization. His most cited work (2024, 31 citations) demonstrates the potential to revolutionize drug development by combining bioprinting precision with advanced chip architectures that mimic human physiology. A subsequent study (2024, 7 citations) further refines robotic-assisted biomanufacturing, addressing the gap between laboratory prototypes and industrial-scale production. By tackling the challenges of reproducibility and throughput, Blaeser is helping to translate OOC technology from academic research into viable commercial tools, with projected market growth underscoring the impact of his work. His achievements position him as a key innovator in the next generation of preclinical testing platforms.
Research Focus
Key Achievements
Top Papers
- 1
- 2